Darin Lippoldt compensation by year
NEUROCRINE BIOSCIENCES Summary Compensation Table · all 3 fiscal years held| Component | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Salary | $486,200 | $525,100 | $548,730 |
| Bonus | $170,170 | $262,550 | $315,520 |
| Stock awards | $2,312,780 | $2,312,606 | $1,550,136 |
| Option awards | $2,437,508 | $2,437,544 | $2,250,049 |
| Non-equity incentive | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $45,704 | $52,361 | $56,761 |
| Total | $5,452,362 | $5,590,161 | $4,721,196 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEUROCRINE BIOSCIENCES INC DEF 14A filed April 5, 2023, accession 0000914475-23-000032, and prior-year filings. Open the filing on EDGAR.
How this page was built: the NEUROCRINE BIOSCIENCES INC filed document, accession 0000914475-23-000032. Every figure is read from that document and cited to the page and table it appears in. Filed April 5, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 12,752 | $1,523,099 | — |
| PSU | 10,125 | $1,209,330 | — |
| RSU | 9,492 | $1,133,724 | — |
| RSU | 5,181 | $618,819 | — |
| RSU | 3,949 | $471,669 | — |
| RSU | 2,892 | $345,420 | — |
| Option | 2,604 | — | $81.05 |
| Option | 14,538 | — | $102.90 |
| Option | 24,671 | — | $117.63 |
| Option | 51,172 | — | $79.02 |
Per the Outstanding Equity Awards at Fiscal Year-End table in NEUROCRINE BIOSCIENCES INC's FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
51 Form 4 lines since the FY2022 proxy (filed April 5, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-11 | Grant or award | — | 4,483 | $0.00 | 59,212 |
| 2026-09-11 | Tax withholding | — | 2,419 | $156.22 | 56,793 |
| 2026-07-09 | Exercise or conversion | 10b5-1 | 10,000 | $81.49 | 64,729 |
| 2026-07-09 | Sale | 10b5-1 | 10,000 | $179.60 | 54,729 |
| 2026-07-09 | Exercise or conversion derivative | 10b5-1 | 10,000 | $0.00 | 4,965 |
| 2026-06-29 | Exercise or conversion | 10b5-1 | 8,110 | $81.49 | 62,839 |
| 2026-06-29 | Exercise or conversion | 10b5-1 | 1,690 | $81.49 | 56,419 |
| 2026-06-29 | Exercise or conversion derivative | 10b5-1 | 8,110 | $0.00 | 16,655 |
The 8 most recent of 51 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
NEUROCRINE BIOSCIENCES’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Kevin C. Gorman | Chief Executive Officer | $11,902,527 |
| Eiry Roberts | Chief Medical Officer | $5,735,281 |
| Kyle W. Gano | Chief Business Development and Strategy Officer | $5,421,657 |
| Matthew C. Abernethy | Chief Financial Officer | $4,924,323 |
| Darin Lippoldt · this page | Chief Legal Officer | $4,721,196 |
The full NEUROCRINE BIOSCIENCES compensation record
free company briefThis page is one person within NEUROCRINE BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the NEUROCRINE BIOSCIENCES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEUROCRINE BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.